Sinsin Pharmaceutical Co. Ltd (002800) — Cash Flow Reinvestment Rate
Sinsin Pharmaceutical Co. Ltd (002800) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting ₩972.34 Million (capex ₩871.54 Million plus investments ₩-100.80 Million) from operating cash flow of ₩4.70 Billion. See 002800 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sinsin Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Sinsin Pharmaceutical Co. Ltd generate cash.
Annual Cash Flow Reinvestment Rate for Sinsin Pharmaceutical Co. Ltd (2015–2024)
Year-by-year capital reinvestment analysis for Sinsin Pharmaceutical Co. Ltd. See Sinsin Pharmaceutical Co. Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.19x | ₩7.07 Billion | ₩5.94 Billion | ₩1.51 Billion | ▼ -57.8% |
| 2023 | 2.82x | ₩11.08 Billion | ₩3.93 Billion | ₩5.03 Billion | ▲ +1320.4% |
| 2022 | 0.20x | ₩1.08 Billion | ₩5.46 Billion | ₩907.13 Million | ▼ -99.8% |
| 2021 | 115.84x | ₩2.69 Billion | ₩23.18 Million | ₩2.68 Billion | ▲ +1363.9% |
| 2020 | 7.91x | ₩14.76 Billion | ₩1.87 Billion | ₩11.97 Billion | ▼ -75.9% |
| 2018 | 32.86x | ₩25.44 Billion | ₩774.24 Million | ₩25.44 Billion | ▲ +4099.6% |
| 2017 | 0.78x | ₩3.57 Billion | ₩4.57 Billion | ₩3.57 Billion | ▼ -70.8% |
| 2016 | 2.68x | ₩7.48 Billion | ₩2.79 Billion | ₩7.43 Billion | ▲ +168.4% |
| 2015 | 1.00x | ₩5.22 Billion | ₩5.24 Billion | ₩5.22 Billion | — |